Agency Forms Undergoing Paperwork Reduction Act Review, 60199-60200 [2017-27257]
Download as PDF
<![CDATA[
60199
Federal Register / Vol. 82, No. 242 / Tuesday, December 19, 2017 / Notices
Assisted Living, American Seniors
Housing Association, Argentum
(formerly Assisted Living Federation of
America), National Adult Day Services
Association; universities; foundations;
and other private sector organizations
such as the Alzheimer’s Association and
the AARP Public Policy Institute.
Expected burden from data collection
for eligible cases is 80 minutes per
respondent: 5 minutes for a contact
confirmation call; 15 minutes for a
screener and appointment setting call;
30 minutes for a provider questionnaire;
and 30 minutes for a sampling and
services user questionnaire. We estimate
an eligibility rate for ADSCs of 86% and
for RCCs of 76%. One-year clearance
requested to cover the collection of data.
The burden for the collection shown in
Table 1 below. There is no cost to
respondents other than their time to
participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
RCC/ADSC
Director/Designated
Staff Member.
RCC/ADSC
Director/Designated
Staff Member.
RCC Director/Designated Staff Member.
ADSC Director/Designated Staff
Member.
RCC Director/Designated Staff Member.
ADSC Director/Designated Staff
Member.
Contact Confirmation Call ................
3,740
1
5/60
312
Screener and Appointment Setting
Call.
RCC Provider Questionnaire ...........
3,740
1
15/60
935
1,589
1
30/60
795
ADSC Provider Questionnaire .........
1,419
1
30/60
710
RCC Sampling and Services User
Questionnaire.
ADSC Sampling and Services User
Questionnaire.
1,589
1
30/60
795
1,419
1
30/60
710
Total ...........................................
...........................................................
........................
........................
........................
4,257
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–27258 Filed 12–18–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–17AMP]
sradovich on DSK3GMQ082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Evaluation of
the SAMHSA Naloxone Education and
Distribution Program to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on July 17,
2017 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
VerDate Sep<11>2014
17:47 Dec 18, 2017
Jkt 244001
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Evaluation of the SAMHSA Naloxone
Education and Distribution Program—
New—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Overdose deaths involving
prescription opioids and heroin have
reached epidemic levels in the U.S. and
continue to rise. To address the
prescription drug/opioid overdose
crisis, the federal government has
recently allocated funding to improve
access to treatment for opioid use
disorders, reduce opioid related deaths,
and strengthen prevention efforts. One
program resulting from the federal
government’s efforts to address the
opioid crisis is the Substance Abuse and
Mental Health Services Agency
(SAMHSA) Grants to Prevent
Prescription Drug/Opioid OverdoseRelated Deaths. This proposed
information collection project will help
evaluate this program.
Through this program, SAMHSA
awarded funding to 12 states. The
funding is aimed at reducing the
number of prescription drug/opioid
overdose-related deaths and adverse
events among individuals 18 years of
E:\FR\FM\19DEN1.SGM
19DEN1
60200
Federal Register / Vol. 82, No. 242 / Tuesday, December 19, 2017 / Notices
age and older through educating and
training first responders and other key
community sectors on the prevention of
prescription drug/opioid overdoserelated deaths, including the purchase
and distribution of naloxone. SAMHSA
is funding the grant and CDC is
responsible for conducting the grantee
evaluation.
The intended use of the resulting data
is to increase CDC and SAMHSA
understanding of the scope and impact
of the program on overdose fatalities
responders, social service providers,
laypersons including end users and
their family and friend. All focus groups
and interviews will be analyzed through
qualitative content analysis, including
utilization of a systematic coding
scheme.
Total burden in hours for this
collection is 381. There are no costs to
respondents other than their time. CDC
requests a three-year OMB approval to
collect the necessary project-related
information.
and how program effectiveness may
vary among different sub-populations
and settings, and to increase knowledge
of barriers and facilitators to program
implementation.
Researchers will use key informant
interviews and focus groups with
participants in the activities enacted by
the twelve state grant recipients.
Participants will include state
administrators of the grant and other
PDO/Naloxone stakeholders including
advisory council members, first
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Type of respondents
Form name
PDO/Naloxone Advisory Committee Members
and Grantees.
PDO/Naloxone Grantees ................................
PDO/Naloxone Stakeholders and Partners ....
PDO/Naloxone Laypersons ............................
Focus Group Discussion Guide .....................
140
1
1.5
Key Informant Interview Guide for Grantees
Key Informant Interview Guide for Partners ..
Key
Informant
Interview
Guide
for
Laypersons.
Recruitment contact script .............................
36
84
24
1
1
1
1
1
1
284
1
5/60
Key Informant Selection Tool .........................
12
1
15/60
All participants (PDO Naloxone grantees, advisory committee, stakeholders and partners, laypersons).
PDO/Naloxone Grantees ................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–27257 Filed 12–18–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: ACF Generic Clearance for
Mandatory Grant Financial Reports.
OMB No.: 0970—New.
Description: OMB has granted
permission for ACF to submit a request
for a generic clearance to be used for the
financial reports used in the
administration of mandatory grants.
This clearance supports the
Departments initiative of Generating
Efficiencies through Streamlined
Processes by employing an abbreviated
process.
If approved program offices will be at
liberty to tailor a financial report to their
specific needs rather than adhering to a
standard form.
Respondents: States and Territories.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Mandatory Grant Financial Reports .................................................................
sradovich on DSK3GMQ082PROD with NOTICES
Instrument
900
4
5
18,000
Estimated Total Annual Burden
Hours:
In compliance with the requirements
of the Paperwork Reduction Act of 1995
(Pub. L. 104–13, 44 U.S.C. Chap. 35), the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
VerDate Sep<11>2014
17:47 Dec 18, 2017
Jkt 244001
Families, Office of Planning, Research
and Evaluation, 330 C Street SW,
Washington, DC 20201. Attn: ACF
Reports Clearance Officer. Email
address: infocollection@acf.hhs.gov. All
requests should be identified by the title
of the information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 82, Number 242 (Tuesday, December 19, 2017)]
[Notices]
[Pages 60199-60200]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-27257]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-17AMP]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Evaluation of the SAMHSA Naloxone Education
and Distribution Program to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
July 17, 2017 to obtain comments from the public and affected agencies.
CDC did not receive comments related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Evaluation of the SAMHSA Naloxone Education and Distribution
Program--New--National Center for Injury Prevention and Control
(NCIPC), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Overdose deaths involving prescription opioids and heroin have
reached epidemic levels in the U.S. and continue to rise. To address
the prescription drug/opioid overdose crisis, the federal government
has recently allocated funding to improve access to treatment for
opioid use disorders, reduce opioid related deaths, and strengthen
prevention efforts. One program resulting from the federal government's
efforts to address the opioid crisis is the Substance Abuse and Mental
Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/
Opioid Overdose-Related Deaths. This proposed information collection
project will help evaluate this program.
Through this program, SAMHSA awarded funding to 12 states. The
funding is aimed at reducing the number of prescription drug/opioid
overdose-related deaths and adverse events among individuals 18 years
of
[[Page 60200]]
age and older through educating and training first responders and other
key community sectors on the prevention of prescription drug/opioid
overdose-related deaths, including the purchase and distribution of
naloxone. SAMHSA is funding the grant and CDC is responsible for
conducting the grantee evaluation.
The intended use of the resulting data is to increase CDC and
SAMHSA understanding of the scope and impact of the program on overdose
fatalities and how program effectiveness may vary among different sub-
populations and settings, and to increase knowledge of barriers and
facilitators to program implementation.
Researchers will use key informant interviews and focus groups with
participants in the activities enacted by the twelve state grant
recipients. Participants will include state administrators of the grant
and other PDO/Naloxone stakeholders including advisory council members,
first responders, social service providers, laypersons including end
users and their family and friend. All focus groups and interviews will
be analyzed through qualitative content analysis, including utilization
of a systematic coding scheme.
Total burden in hours for this collection is 381. There are no
costs to respondents other than their time. CDC requests a three-year
OMB approval to collect the necessary project-related information.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
PDO/Naloxone Advisory Committee Focus Group Discussion 140 1 1.5
Members and Grantees. Guide.
PDO/Naloxone Grantees................. Key Informant Interview 36 1 1
Guide for Grantees.
PDO/Naloxone Stakeholders and Partners Key Informant Interview 84 1 1
Guide for Partners.
PDO/Naloxone Laypersons............... Key Informant Interview 24 1 1
Guide for Laypersons.
All participants (PDO Naloxone Recruitment contact 284 1 5/60
grantees, advisory committee, script.
stakeholders and partners,
laypersons).
PDO/Naloxone Grantees................. Key Informant Selection 12 1 15/60
Tool.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-27257 Filed 12-18-17; 8:45 am]
BILLING CODE 4163-18-P
